SPUR THERAPEUTICS
Spur Therapeutics is a clinical-stage biotechnology business dedicated to creating life-changing medicines for crippling chronic illnesses.
SPUR THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2024-01-01
Address:
Stevenage, Herefordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.spurtherapeutics.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
50 M USD
Current Advisors List
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2024-06-17 | Freeline | Freeline acquired by Spur Therapeutics | N/A |
2024-06-17 | SwanBio Therapeutics | SwanBio Therapeutics acquired by Spur Therapeutics | N/A |
Investors List
Syncona Partners LLP
Syncona Partners LLP investment in Private Equity Round - Spur Therapeutics
Official Site Inspections
http://www.spurtherapeutics.com
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Spur Therapeutics"
Spur Therapeutics | Toward Moreโข
Spur Therapeutics is a clinical-stage biotech that optimizes every component of its gene therapy candidates to change the course of diseasesโand change lives.See details»
Spur Therapeutics - Crunchbase Company Profile & Funding
Organization. Spur Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. About. Spur Therapeutics is a clinical-stage biotechnology โฆSee details»
Spur Therapeutics - LinkedIn
Spur Therapeutics (formerly Freeline Therapeutics) is a clinical-stage biotechnology company focused on developing life-changing therapies for debilitating chronic conditions.See details»
Spur Therapeutics Company Overview, Contact Details
Jun 17, 2024 Broad Therapeutic Focus Spur Therapeutics is expanding its pipeline beyond rare diseases to target more widespread conditions like Parkinson's and dementia, providing a โฆSee details»
Spur Therapeutics - Funding, Financials, Valuation & Investors
Jun 17, 2024 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jun 17, 2024: โฆSee details»
SPR Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 844 378 9108 SPRA Therapeutics is a medical device company that is commercializing pain treatments utilizing its proprietary โฆSee details»
SPR Therapeutics - Overview, News & Similar companies - ZoomInfo
Jan 31, 2024 SPR Therapeutics contact info: Phone number: (844) 378-9108 Website: www.sprtherapeutics.com What does SPR Therapeutics do? SPR Therapeutics is a medical โฆSee details»
Creation of Spur Therapeutics - PharmiWeb.com
Jun 17, 2024 Syncona Limited Creation of Spur Therapeutics 17 June 2024 โข Freeline acquires SwanBio to create a new company, Spur Therapeutics, combining two of Synconaโs clinical โฆSee details»
Creation of Spur Therapeutics โ Company Announcement - FT.com
Jun 17, 2024 [1] The 31 December 2023 valuation of SwanBio (£74.6m) and Freeline (£20.5m), pro-rata for the movement in share price to the acquisition date and the consideration paid for โฆSee details»
Spur Therapeutics (Formerly Freeline) Announces New Name
Jun 17, 2024 With a mission to redefine what gene therapy can do, Spur is optimizing every component of its product candidates to develop a new generation of gene therapiesSee details»
Syncona Unveils Spur Therapeutics for Gene Therapy Advancements
Jun 17, 2024 Syncona Shs GBP (GB:SYNC) has released an update.Syncona Limited has announced the creation of Spur Therapeutics through the acquisition of SwanBio by Freeline, โฆSee details»
Spur Therapeutics | Clinical companies | Portfolio - Syncona
Investment thesis. Spur has two potential first-in-class gene therapy programmes. Its lead programme is a highly differentiated gene therapy candidate, FLT201, for Gaucher disease โฆSee details»
Spur Therapeutics (Formerly Freeline) Announces New Name and โฆ
Jun 17, 2024 Spur today also announced its acquisition of SwanBio Therapeutics, which adds a potential first-in-class gene therapy program for adrenomyeloneuropathy (AMN), a devastating โฆSee details»
SPR Therapeutics โ SPRINT PNS System
The SPRINT PNS System is indicated for up to 60 days for: (i) Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; (ii) Symptomatic relief of post โฆSee details»
Working At SPR Therapeutics: Company Overview and Culture
Mar 14, 2024 www.sprtherapeutics.com. Organization Type. Private. CEO. Maria E. Bennett. SPRA Therapeutics is a medical device company that is commercializing pain treatments โฆSee details»
SPR Therapeutics Named a Top Workplace for Second โฆ
Jun 25, 2023 The Top Workplaces awards highlight companies based on employee feedback on a set of 15 culture driving factors that are deemed critical of the success of an organization. Of โฆSee details»
Spur Therapeutics (Formerly Freeline) Announces New Name and โฆ
Jun 17, 2024 With a mission to redefine what gene therapy can do, Spur is optimizing every component of its product candidates to develop a new generation of gene therapiesSee details»
SPR® Therapeutics Recognized as a Top Workplace in Northeast โฆ
Jun 23, 2024 โ Corporate culture remains a strength as the company experienced dynamic growth โ Cleveland, Ohio โ June 23, 2024 โ SPR Therapeutics has been honored as a Top โฆSee details»
SPR® Therapeutics Announces $85 Million in Additional Funding โฆ
CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients โฆSee details»
Ben Austin, CFO and COO of SPR® Therapeutics, Named to Crainโs ...
Nov 18, 2024 Please reach out to our Patient Support team by calling 1-844-378-9108 and selecting option 1 from the menu between 8:00 a.m. and 5:00 p.m. EST. If more convenient, โฆSee details»